WHO ICTRP trial

Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market…

NL-OMON49230 · Overview of Medical Research in the Netherlands (NL-OMON)

Key facts

Trial ID NL-OMON49230
Public title Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market Study (MiBAND): A European prospective, multicenter study to assess transcatheter mitral valve repair with Edwards Cardioband System in patients with symptomatic mitral regurgitation.
Scientific title Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market Study (MiBAND): A European prospective, multicenter study to assess transcatheter mitral valve repair with Edwards Cardioband System in patients with symptomatic mitral regurgitation. - MiBAND Study
Primary sponsor Edwards Lifesciences, LCC
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Study type Observational non invasive
Phase 4
Countries France;Germany;Italy;Netherlands;Switzerland
Conditions mitral insufficiency Mitral valve regurgitation;10019280;mitral insufficiency;Mitral valve regurgitation
Interventions mitral valve repair with Edwards Cardioband System ;Edwards Cardioband System;Mitral valve;Post-Market Clinical Follow-Up;Transcatheter
Registration date Feb 13, 2020
Target size 5
Secondary IDs NCT03600688;NL71033.058.19
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations